Gene · 6926
Papers2,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,253
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An expedition in the jungle of pluripotent stem cells of non-human primates. | Stem Cell Reports | 2023 | 37863046 | PubTator, text mining | PubMed |
| Localized T3 production modifies the transcriptome and promotes the hepatocyte-like lineage in iPSC-derived hepatic organoids. | JCI Insight | 2023 | 37856222 | PubTator, text mining | PubMed |
| A spatial sequencing atlas of age-induced changes in the lung during influenza infection. | Nat Commun | 2023 | 37852965 | PubTator, text mining | PubMed |
| The Role of Checkpoint Inhibitor Expression Directly on Exfoliated Cells from Bladder Cancer: A Narrative Review. | Diagnostics (Basel) | 2023 | 37835862 | PubTator, text mining | PubMed |
| Noncoding RNAs and Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Cardiac Arrhythmic Brugada Syndrome. | Cells | 2023 | 37830612 | PubTator, text mining | PubMed |
| FGFR2 genetic variants in women with breast cancer. | Mol Med Rep | 2023 | 37830168 | PubTator, text mining | PubMed |
| TBX3 promotes the epithelial mesenchymal transition of cervical cancer by upregulating ID1. | Am J Cancer Res | 2023 | 37818083 | PubTator, text mining | PubMed |
| Retracted: MicroRNA-143-3p/TBX3 Axis Represses Malignant Cell Behaviors in Bladder Cancer. | Comput Math Methods Med | 2023 | 37799428 | PubTator, text mining | PubMed |
| The transcription factor EBF1 non-cell-autonomously regulates cardiac growth and differentiation. | Development | 2023 | 37787076 | PubTator, text mining | PubMed |
| Elongation roadblocks mediated by dCas9 across human genes modulate transcription and nascent RNA processing. | Nat Struct Mol Biol | 2023 | 37783853 | PubTator, text mining | PubMed |
| Are We Ready to Reclassify Crohn's Disease Using Molecular Classification? | J Clin Med | 2023 | 37762727 | PubTator, text mining | PubMed |
| Evaluating the Utility of ctDNA in Detecting Residual Cancer and Predicting Recurrence in Patients with Serous Ovarian Cancer. | Int J Mol Sci | 2023 | 37762691 | PubTator, text mining | PubMed |
| Ginsenoside F1-Mediated Telomere Preservation Delays Cellular Senescence. | Int J Mol Sci | 2023 | 37762556 | PubTator, text mining | PubMed |
| Discovery of TBX20 as a Novel Gene Underlying Atrial Fibrillation. | Biology (Basel) | 2023 | 37759586 | PubTator, text mining | PubMed |
| Clinical Utility of Ivosidenib in the Treatment of IDH1-Mutant Cholangiocarcinoma: Evidence To Date. | Cancer Manag Res | 2023 | 37746315 | PubTator, text mining | PubMed |
| Social environment characteristics are related to self-rated health in four Latin America countries: Evidence from the SALURBAL Project. | Health Place | 2023 | 37708687 | PubTator, text mining | PubMed |
| Chromatin loop dynamics during cellular differentiation are associated with changes to both anchor and internal regulatory features. | Genome Res | 2023 | 37699658 | PubTator, text mining | PubMed |
| Genomic Alterations Associated with Estrogen Receptor Pathway Activity in Metastatic Breast Cancer Have a Differential Impact on Downstream ER Signaling. | Cancers (Basel) | 2023 | 37686693 | PubTator, text mining | PubMed |
| Hepatocellular Carcinoma: Past and Present Challenges and Progress in Molecular Classification and Precision Oncology. | Int J Mol Sci | 2023 | 37686079 | PubTator, text mining | PubMed |
| The effectiveness of mindfulness yoga on patients with major depressive disorder: a systematic review and meta-analysis of randomized controlled trials. | BMC Complement Med Ther | 2023 | 37684609 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6926/papers?page=9